Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by D Seshagiri
Cost Effectiveness of Bortezomib, Rituximab, Cyclophosphamide, Doxorubicin and Prednisone for the First-Line Treatment of Mantle Cell Lymphoma Not Eligible for Stem Cell Transplantation: A Scottish Perspective
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Durable Remission of Mantle Cell Lymphoma Relapsing a Third Time After Allogeneic Hematopoietic Stem Cell Transplantation Treated With Rituximab, Bortezomib, Donor Lymphocytes, and Pegylated Interferon
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
A Phase II Study of Bortezomib Added to Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Previously Untreated Indolent Non-Hodgkin's Lymphoma
British Journal of Haematology
Hematology
Economics of Stem Cell Transplantation for Lymphoma: Counting the Cost of Living
British Journal of Cancer
Cancer Research
Oncology
Rituximab and Autologous Stem-Cell Transplantation for High-Risk Diffuse Large B-Cell Lymphoma – Authors' Reply
The Lancet Oncology
Oncology
Role of Radiotherapy in Diffuse Large B‐cell Lymphoma in Advanced Stages on Complete Response After Administration of Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, and Rituximab
Precision Radiation Oncology
Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation for Adults With Relapsed and Refractory Mantle Cell Lymphoma: A Single Center Retrospective Analysis in the Rituximab Era
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Stem Cell Transplantation for Mantle Cell Lymphoma: Should It Ever Be Used Outside Clinical Trials?
Bone Marrow Transplantation
Transplantation
Hematology
Emerging Therapy for the Treatment of Mantle Cell Lymphoma
Journal of the National Comprehensive Cancer Network : JNCCN
Medicine
Oncology
Autologous Stem Cell Transplantation in First Remission Significantly Prolongs Progression-Free and Overall Survival in Mantle Cell Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
